Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease

Autor: Martínez-Domínguez, Samuel J., García-Mateo, Sandra, Gargallo-Puyuelo, Carla J., Gallego Llera, Beatriz, Refaie, Engy, Callau, Pilar, Mendi, Carolina, Baptista, Pedro M., Hernández Ainsa, María, Arroyo-Villarino, María Teresa, López de la Cruz, Julia, Martínez-García, Javier, Alfambra, Erika, Simón Marco, Miguel Ángel, Ampuero, Javier, Gomollón, Fernando

Publikováno v: In European Journal of Internal Medicine February 2024 120:99-106

When metabolic comorbidities and risk of malnutrition coexist: The new era of inflammatory bowel disease

Autor: García-Mateo, Sandra, Martínez-Domínguez, Samuel Jesús, Gargallo-Puyuelo, Carla Jerusalén, Villarino, María Teresa Arroyo, Laredo, Viviana, Gallego, Beatriz, Alfambra, Erika, Sanz, Borja, Gomollón, Fernando

Publikováno v: In The American Journal of the Medical Sciences July 2024

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

Autor: Rocca, Rodolfo, Lopes, Susana, Caprioli, Flavio, Ardizzone, Sandro, Echarri Piudo, Ana, Gionchetti, Paolo, Roblin, Xavier, Seidler, Ursula, Andersson, David, Patel, Kamal, Desreumaux, Pierre, Saibeni, Simone, From, Gustav, Fedurco, Miroslav, Gregus, Milos, Bouhnik, Yoram, Luegering, Andreas, Cosintino, Rocco, Bunganic, Ivan, Ramos, Jaime, Aguas Peris, Mariam, Dewit, Olivier, Principi, Mariabeatrice, Wesley, Emma, Lago, Paula, Nancey, Stephane, Martín Arranz, María Dolores, Hindryckx, Pieter, Orlando, Ambrogio, Geccherle, Andrea, Annunziata, Maria Laura, Hayee, Bu'hussain, Balaz, Jozef, Portela, Francisco, Gilletta, Cyrielle, Kucharzik, Torsten, Mínguez, Miguel, Gisbert, Javier Pérez, Casbas, Ana Gutiérrez, Louis, Edouard, Marino, Marco, Parkes, Gareth, Cummings, Fraser, Jharap, Bindia, Kjeldsen, Jens, Correia, Luís, Ministro, Paula, Ebert, Matthias, Hertervig, Erik, Staessen, Dirk, Dutré, Joris, Colard, Arnaud, Morrison, Graham, Glerup, Henning, Dahlerup, Jens Frederik, Wolfhagen, Frank, Batovsky, Marian, Molnar, Martin, Kadleckova, Barbora, Caldeira, Paulo, Laharie, David, Hebuterne, Xavier, Bonaz, Bruno, Allez, Matthieu, Fischer, Andreas, Hinojosa Del Val, Joaquín Ernesto, Ciria, Miriam Mañosa, Herrera Justiniano, Jose Manuel, Soderman, Charlotte, Chandy, Rajiv, Mowat, Craig, Irving, Peter, Fallingborg, Jan, Matous, Jan, Douda, Tomas, Altwegg, Romain, Benitez, Jose Manuel, Arroyo Villarino, María Teresa, Capón, Jordi Guardiola, Vicenc, Daniel Ginard, Dewint, Pieter, Almer, Sven, Kindt, Sebastien, Danese, Silvio ^*, Vermeire, Severine, D'Haens, Geert, Panés, Julian, Dignass, Axel, Magro, Fernando, Nazar, Maciej, Le Bars, Manuela, Lahaye, Marjolein, Ni, Lioudmila, Bravata, Ivana, Lavie, Frederic, Daperno, Marco, Lukáš, Milan, Armuzzi, Alessandro, Löwenberg, Mark, Gaya, Daniel R, Peyrin-Biroulet, Laurent

Publikováno v: In The Lancet Gastroenterology & Hepatology April 2022 7(4):294-306

Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease

Autor: Refaie, Engy, García Mateo, Sandra, Martínez Domínguez, Samuel Jesús, Gargallo-Puyuelo, Carla Jerusalén, Lario Quilez, Laura, Carrera-Lasfuentes, Patricia, Arroyo Villarino, María Teresa, Gomollón García, Fernando

Publikováno v: In Gastroenterología y Hepatología (English Edition) February 2022 45(2):114-122

Clinical value of CT-P13 trough levels, an infliximab biosimilar, in the management of inflammatory bowel disease

Autor: Elosua González, Alfonso ^*, Sanz Segura, Patricia, Oyón Lara, Daniel, López García, Santiago, Arroyo Villarino, Maria Teresa, Alcalá Escriche, Maria José, Ollero Domenche, Leticia, Rodríguez Gutiérrez, Cristina, Nantes Castillejo, Óscar

Publikováno v: In Medicina Clínica (English Edition) 26 June 2020 154(12):475-480